# Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States

> **NCT02867722** · NA · WITHDRAWN · sponsor: **Brigham and Women's Hospital**

## Conditions studied

- Actinic Keratosis
- Non-melanoma Skin Cancer

## Interventions

- **DRUG:** aminolevulinic acid HCl

## Key facts

- **NCT ID:** NCT02867722
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The PI decided to not proceed with the trial due to lack of funding.
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867722, "Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States". Retrieved via MORVS 2026-10-06 from https://api.morvs.ai/clinical/NCT02867722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*